These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16850005

  • 1. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
    Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM.
    Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
    [Abstract] [Full Text] [Related]

  • 2. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
    Uehara A, Yang S, Fujimoto Y, Fukase K, Kusumoto S, Shibata K, Sugawara S, Takada H.
    Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
    [Abstract] [Full Text] [Related]

  • 3. Impaired monocyte Toll-like receptor-4 signaling in trauma and sepsis: is SIGIRR the answer?
    Wang JE, Dahle MK, Aasen AO.
    Crit Care Med; 2006 Sep; 34(9):2498-500. PubMed ID: 16921326
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K.
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [Abstract] [Full Text] [Related]

  • 5. [Role of transduce molecules and modulatory factors of signal pathways of Toll-like receptor in inflammatory response of children with sepsis].
    Yang WG, Li CR, He YX, Wang GB, Zu Y.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):561-4. PubMed ID: 18786322
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.
    Uehara A, Sugawara Y, Kurata S, Fujimoto Y, Fukase K, Kusumoto S, Satta Y, Sasano T, Sugawara S, Takada H.
    Cell Microbiol; 2005 May; 7(5):675-86. PubMed ID: 15839897
    [Abstract] [Full Text] [Related]

  • 9. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass.
    Hadley JS, Wang JE, Michaels LC, Dempsey CM, Foster SJ, Thiemermann C, Hinds CJ.
    Shock; 2007 May; 27(5):466-73. PubMed ID: 17438450
    [Abstract] [Full Text] [Related]

  • 10. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H, Bogaert S, Laukens D, Rottiers P, De Keyser F, Darfeuille-Michaud A, Glasser AL, Elewaut D, De Vos M.
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
    Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J.
    Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
    [Abstract] [Full Text] [Related]

  • 13. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
    Hawn TR, Ozinsky A, Williams LM, Rodrigues S, Clark A, Pham U, Hill HR, Ochs H, Aderem A, Liles WC.
    Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
    [Abstract] [Full Text] [Related]

  • 14. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD, Vandenplas ML, Hurley DJ, Moore JN.
    Vet Immunol Immunopathol; 2009 Jan 15; 127(1-2):125-34. PubMed ID: 19019456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
    Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, Cavaillon JM, Philpott DJ, Adib-Conquy M.
    Eur J Immunol; 2005 Aug 15; 35(8):2459-70. PubMed ID: 16021602
    [Abstract] [Full Text] [Related]

  • 18. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B, Zhang R, Li J, Zhang L, Ding G, Luo P, He S, Dong Y, Jiang W, Lu Y, Cao H, Zheng J, Zhou H.
    Int Immunopharmacol; 2008 Mar 15; 8(3):379-89. PubMed ID: 18279792
    [Abstract] [Full Text] [Related]

  • 19. Contribution of phagocytosis and intracellular sensing for cytokine production by Staphylococcus aureus-activated macrophages.
    Kapetanovic R, Nahori MA, Balloy V, Fitting C, Philpott DJ, Cavaillon JM, Adib-Conquy M.
    Infect Immun; 2007 Feb 15; 75(2):830-7. PubMed ID: 17118979
    [Abstract] [Full Text] [Related]

  • 20. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
    Tsujimoto H, Ono S, Majima T, Efron PA, Kinoshita M, Hiraide H, Moldawer LL, Mochizuki H.
    Clin Immunol; 2006 May 15; 119(2):180-7. PubMed ID: 16517212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.